Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $1.58, $0.16 better than the analyst estimate of $1.42. Revenue for the quarter came in at $11.49 billion versus the consensus estimate of $10.92 billion.

GUIDANCE:

Bristol-Myers Squibb sees FY2026 EPS of $6.05-$6.35, versus the consensus of $6.26. Bristol-Myers Squibb sees FY2026 revenue of $46-47.5 billion, versus the consensus of $47.12 billion.

For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.